Deep Domain Adversarial Learning for Species-Agnostic Classification of Histologic Subtypes of Osteosarcoma.


Journal

The American journal of pathology
ISSN: 1525-2191
Titre abrégé: Am J Pathol
Pays: United States
ID NLM: 0370502

Informations de publication

Date de publication:
01 2023
Historique:
received: 27 06 2022
revised: 31 08 2022
accepted: 28 09 2022
pubmed: 30 10 2022
medline: 20 12 2022
entrez: 29 10 2022
Statut: ppublish

Résumé

Osteosarcomas (OSs) are aggressive bone tumors with many divergent histologic patterns. During pathology review, OSs are subtyped based on the predominant histologic pattern; however, tumors often demonstrate multiple patterns. This high tumor heterogeneity coupled with scarcity of samples compared with other tumor types render histology-based prognosis of OSs challenging. To combat lower case numbers in humans, dogs with spontaneous OSs have been suggested as a model species. Herein, a convolutional neural network was adversarially trained to classify distinct histologic patterns of OS in humans using mostly canine OS data during training. Adversarial training improved domain adaption of a histologic subtype classifier from canines to humans, achieving an average multiclass F1 score of 0.77 (95% CI, 0.74-0.79) and 0.80 (95% CI, 0.78-0.81) when compared with the ground truth in canines and humans, respectively. Finally, this trained model, when used to characterize the histologic landscape of 306 canine OSs, uncovered distinct clusters with markedly different clinical responses to standard-of-care therapy.

Identifiants

pubmed: 36309101
pii: S0002-9440(22)00319-4
doi: 10.1016/j.ajpath.2022.09.009
pmc: PMC9798510
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

60-72

Subventions

Organisme : Intramural NIH HHS
ID : ZIH BC012032
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Références

J Vet Intern Med. 2014 Mar-Apr;28(2):554-63
pubmed: 24512451
Vet Pathol. 2015 Sep;52(5):977-84
pubmed: 25770040
Arch Pathol Lab Med. 2012 May;136(5):572-6
pubmed: 22540307
J Comp Pathol. 1995 May;112(4):319-26
pubmed: 7593754
Vet Pathol. 2022 May;59(3):399-414
pubmed: 35341404
Med Phys. 2020 Oct;47(10):4895-4905
pubmed: 32677073
JCO Clin Cancer Inform. 2020 Apr;4:367-382
pubmed: 32330067
J Pediatr Hematol Oncol. 2003 Nov;25(11):840-1
pubmed: 14608191
Cancer Treat Res. 2009;152:3-13
pubmed: 20213383
Vet Comp Oncol. 2017 Dec;15(4):1232-1239
pubmed: 27507032
Mod Pathol. 2021 Dec;34(12):2098-2108
pubmed: 34168282
Vet Comp Oncol. 2016 Mar;14(1):81-7
pubmed: 24118677
Nat Biomed Eng. 2021 Jun;5(6):555-570
pubmed: 33649564
Nat Rev Cancer. 2020 Dec;20(12):727-742
pubmed: 32934365
Sensors (Basel). 2021 Aug 09;21(16):
pubmed: 34450802
Acta Orthop Scand. 2001 Apr;72(2):167-72
pubmed: 11372948
J Comp Pathol. 2020 Apr;176:133-144
pubmed: 32359626
Toxicol Pathol. 2021 Jun;49(4):815-842
pubmed: 33618634
Cancer. 1976 Dec;38(6):2538-47
pubmed: 1069603
Nat Med. 2019 Aug;25(8):1301-1309
pubmed: 31308507
BMC Med Imaging. 2015 Aug 12;15:29
pubmed: 26263899
Onco Targets Ther. 2013 May 28;6:593-602
pubmed: 23745051
J Am Anim Hosp Assoc. 1995 Jul-Aug;31(4):321-6
pubmed: 7552665
Clin Cancer Res. 2016 May 1;22(9):2133-8
pubmed: 26712689
Nat Rev Clin Oncol. 2019 Nov;16(11):703-715
pubmed: 31399699
SICOT J. 2018;4:12
pubmed: 29629690
Clin Orthop Relat Res. 1975 Sep;(111):23-32
pubmed: 168999
J Am Vet Med Assoc. 2013 Jul 1;243(1):96-101
pubmed: 23786196
Clin Cancer Res. 2021 Jun 1;27(11):3005-3016
pubmed: 33753454
Front Public Health. 2022 Jul 04;10:892658
pubmed: 35859771
Comput Biol Med. 2021 Jan;128:104129
pubmed: 33254082
Sci Transl Med. 2016 Feb 3;8(324):324ps5
pubmed: 26843188
Cancer. 1982 Apr 15;49(8):1679-89
pubmed: 6950802
Vet Pathol. 2018 Mar;55(2):202-211
pubmed: 29284372
J Comput Biol. 2018 Mar;25(3):313-325
pubmed: 29083930
Diagn Interv Radiol. 2019 May;25(3):183-188
pubmed: 31063138

Auteurs

Sushant Patkar (S)

Artificial Intelligence Resource, Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, Maryland. Electronic address: patkar.sushant@nih.gov.

Jessica Beck (J)

Comparative Oncology Program, Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, Maryland.

Stephanie Harmon (S)

Artificial Intelligence Resource, Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, Maryland.

Christina Mazcko (C)

Comparative Oncology Program, Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, Maryland.

Baris Turkbey (B)

Artificial Intelligence Resource, Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, Maryland.

Peter Choyke (P)

Artificial Intelligence Resource, Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, Maryland.

G Thomas Brown (GT)

Artificial Intelligence Resource, Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, Maryland.

Amy LeBlanc (A)

Comparative Oncology Program, Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, Maryland. Electronic address: amy.leblanc@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH